Purdue Pharma L.P. announced today that Intermezzo® (zolpidem tartrate) sublingual tablet CIV is now available in 1.75 mg and 3.5 mg dosage strengths by prescription in retail pharmacies nationwide. Intermezzo is the first and only prescription sleep aid approved for middle-of-the-night dosing, and should only be taken once per night in bed, as needed, when a patient wakes up in the middle of the night and has difficulty returning to sleep. Intermezzo is not indicated for use when a patient has fewer than four hours of bedtime remaining before the planned time of waking.
"Patients with middle-of-the-night insomnia now have a treatment option approved for dosing in the middle of the night," said sleep expert, Professor of Family Medicine and Associate Editor of the Delaware Medical Journal Joseph Lieberman M.D., M.P.H. "The availability of Intermezzo is an important treatment option for patients who suffer with this form of insomnia and want a treatment that they can use as needed to fall back to sleep in the middle of the night when they have difficulty returning to sleep."